-
公开(公告)号：US20030138987A1
公开(公告)日：2003-07-24
申请号：US10051069
申请日：2002-01-22
Inventor： Yael Nemirovsky , Raoul Weil , Robert Beserman , Joseph Shamir , Sara Stolyarova , Arye Peyser
IPC: H01L021/00
CPC classification number: H01L31/085 , H01L31/186 , Y02E10/50 , Y02P70/521
Abstract: A method for improving CdZnTe-based gamma-ray detectors is presented. A CdZnTe detector/crystal is exposed to acoustic waves. After exposure to acoustic waves, the CdZnTe gamma-detector gains higher resistivity and exhibits better spectral resolution and greater sensitivity. Further, when a batch of detectors is made according to the method of the present invention, the properties of the crystals are more homogenous, allowing for cheaper and more standardized detectors.
Abstract translation: 提出了一种改进基于CdZnTe的γ射线探测器的方法。 CdZnTe探测器/晶体暴露于声波。 在暴露于声波之后，CdZnTe伽马检测器获得更高的电阻率，并表现出更好的光谱分辨率和更高的灵敏度。 此外，当根据本发明的方法制造一批检测器时，晶体的性质更均匀，允许更廉价和更标准化的检测器。
-
42.发明申请Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis 审中-公开用于调节血管生成和抑制转移和肿瘤纤维化的药物组合物和方法公开(公告)号：US20030114410A1
公开(公告)日：2003-06-19
申请号：US10305348
申请日：2002-11-27
Inventor： Gera Neufeld , Gal Akiri , Zahava Vadasz , Stela Gengrinovitch
IPC: A61K048/00 , A61K039/395
CPC classification number: C12Q1/6886 , A61K38/00 , A61K2039/505 , C07K16/30 , C07K16/40 , C12N9/0022 , C12Q1/26 , C12Y104/03013 , G01N33/574 , G01N33/57419 , G01N2500/00
Abstract: Methods and compositions suitable for modulating angiogenesis in a mammalian tissue are provided. Further provided are methods suitable for inhibiting metastasis and fibrosis in a mammalian tissue.
Abstract translation: 提供适于调节哺乳动物组织中血管生成的方法和组合物。 还提供了适合于抑制哺乳动物组织中的转移和纤维化的方法。
-
43.发明申请公开(公告)号：US20030028360A1
公开(公告)日：2003-02-06
申请号：US10160404
申请日：2002-06-04
Inventor： Ofir Bochobza-Degani , David Elata , Yael Nemirovsky , Eran Socher
IPC: G06F017/10
CPC classification number: B81C99/006 , H02N1/006
Abstract: A method of efficiently extracting the pull-in parameters of an electrostatically activated actuator. The actuator is modeled as an elastic element. For each of a plurality of deformations of the elastic element, a corresponding voltage is calculated. The highest such voltage is the pull-in voltage of the actuator. The corresponding deformation is the pull-in deformation of the actuator. Each deformation is defined by fixing a displacement of one degree of freedom of the elastic body and calculating corresponding equilibrium displacements of all the other degrees of freedom without the application of any external mechanical forces to ensure equilibrium. The actuator is altered to optimize whichever pull-in parameter is relevant to the desired application of the actuator.
Abstract translation: 一种有效提取静电激活致动器的拉入参数的方法。 致动器被建模为弹性元件。 对于弹性元件的多个变形中的每一个，计算相应的电压。 最高的这种电压是执行器的引入电压。 相应的变形是致动器的拉入变形。 通过固定弹性体的一个自由度的位移并计算所有其他自由度的相应的平衡位移来定义每个变形，而不必施加任何外部机械力来确保平衡。 致动器被改变以优化与执行器的期望应用相关的哪个拉入参数。
-
44.发明公开公开(公告)号：US20240044832A1
公开(公告)日：2024-02-08
申请号：US18268638
申请日：2021-12-21
Inventor： Hossam HAICK , Reef EINOCH AMOR , Yoav BROZA
IPC: G01N27/327 , G01N1/22 , G16H50/20 , G16H50/70
CPC classification number: G01N27/3275 , G01N1/2226 , G16H50/20 , G16H50/70 , G01N2001/2229
Abstract: The present invention provides methods of diagnosing cancer in a test subject, comprising exposing an array of chemically sensitive sensors comprising a material selected from the group consisting of conductive nanostructures coated with an organic coating, a conducting polymer and a conductive polymer composite, to a blood sample and a urine sample obtained from the test subject, and analyzing output signals of the chemically sensitive sensors upon exposure of the array to the blood sample and the urine sample. The array of the chemically sensitive sensors can be a part of a portable medical device. Further provided is a method of diagnosing cancer in a test subject, comprising measuring and analyzing levels of a set of volatile organic compounds (VOCs) in a blood sample and a urine sample obtained from the test subject.
-
公开(公告)号：US20230366849A1
公开(公告)日：2023-11-16
申请号：US18044458
申请日：2021-09-02
Inventor： Omer YEHEZKELI , Roy COHEN , Yifat COHEN , Dina MUKAH
IPC: G01N27/327
CPC classification number: G01N27/3278
Abstract: The invention disclosed herein concerns an amperometric enzyme-based biosensor which exhibits high accuracy, high bioelectrocatalytic currents, linear response, low overpotentials and stability.
-
Patent Agency Ranking
公开(公告)号：US20230313391A1
公开(公告)日：2023-10-05
申请号：US18040191
申请日：2021-08-04
Inventor： Gideon GRADER , Avner ROTHSCHILD , Hen DOTAN , Avigail LANDMAN , Asaf KAY , Mordechay MOSHKOVICH
CPC classification number: C25B9/13 , C25B1/04 , C25B9/30 , C25B9/40 , C25B15/087
Abstract: Provided is a system for continuous generation of gases, the system including an electrochemical device and an active- material regeneration device.
-
公开(公告)号：US11646793B2
公开(公告)日：2023-05-09
申请号：US17202241
申请日：2021-03-15
Inventor： Moshe Nazarathy , Amos Agmon , Alexander Tolmachev
IPC: H04B10/25 , H04B10/2575 , H04B10/532 , G02B6/293 , G02B6/28 , G02B6/42
CPC classification number: H04B10/25752 , G02B6/28 , G02B6/29302 , G02B6/29362 , G02B6/29383 , G02B6/4246 , H04B10/532
Abstract: An electro-optic system, the electro-optic system that may include an input port that is configured to receive a bandpass signal that conveys information; wherein the bandpass signal is a radio frequency (RF) signal; an optical carrier source that is configured to generate an optical carrier signal having an optical carrier frequency; at least one electrical bias circuit that is configured to generate at least one electrical bias signal; an electro-optic modulation circuit that is linear at the optical field; a manipulator that is configured to (a) receive the at least one electrical bias signal and the bandpass signal, (b) generate, based on the at least one electrical bias signal and the bandpass signal, at least one modulating signal; wherein the electro-optic modulation circuit is configured to modulate the optical carrier by the at least one modulating signal to provide an output optical signal that comprises at least one optical pilot tone and at least one optical sideband that conveys the information.
-
公开(公告)号：US20230040158A1
公开(公告)日：2023-02-09
申请号：US17780404
申请日：2019-11-27
Inventor： Leon ANAVY , Zohar YAKHINI , Roee AMIT
Abstract: A molecular data storage system is presented for encoding data-block(s). The system includes one or more populations of molecular sequences, each population encoding a respective one of the data-blocks. Each molecular sequence comprises a data encoding section comprising a sequence of similar predetermined length N of short k-mers, whereby in each population the data encoding sections of all molecular sequences have the similar predetermined length N. The short k-mers serve as data encoding building blocks of the data encoding sections, whereby valid short k-mers serving as data encoding building blocks form a subset of a building-block-set consisting of a number Z of different preselected short k-mers each presenting a unique combination of a number k of bases of a preselected set of bases, characterized in that all the Z types of short k-mers in said building-block-set have a similar predetermined size k≥2 (plurality) of bases. The data encoding sections collectively encode a sequence of encoded alphabet letters S=(π1, π2, . . . , πn . . . , πN−1, πN). Each valid encoded alphabet letter πn at location n of the sequence S of alphabet letters is characterized by occurrence of a predetermined plurality of different types of short k-mers of the building-block-set in a corresponding location n along the data encoding sections of the plurality of molecular sequences of said population.
-
49.发明授权公开(公告)号：US11081235B2
公开(公告)日：2021-08-03
申请号：US16432212
申请日：2019-06-05
Inventor： Michal A. Rahat , Nitza Lahat , Miriam Walter , Haim Bitterman
IPC: A61K39/00 , G16H50/30 , C07K16/28 , C07K14/705 , C12N15/62 , G01N33/574 , C07K14/435 , C07K7/06 , C07K7/08 , G01N33/68 , A61K38/00
Abstract: The invention provides isolated peptides from the protein EMMPRIN (CD147/Basigin) and antibodies directed against antigenic determinants within said peptides. Pharmaceutical compositions comprising said peptides and antibodies are also disclosed as well as methods of their production and use in vaccination, immunotherapy and diagnosis of proliferative, hyperpermeability, inflammatory, and angiogenesis-related diseases and disorders.
-
公开(公告)号：US11060092B2
公开(公告)日：2021-07-13
申请号：US16316677
申请日：2017-07-13
Inventor： Izhak Kehat , Alon Abend , Omer Shkedi , Lilac Caspi
IPC: A61K48/00 , C07H21/04 , C12N15/113 , A61P9/10 , A61K31/506 , A61K31/5377 , A61K31/713 , A61K45/06 , A61K38/15 , A61K38/12
Abstract: A pharmaceutical composition and a method of treating, reducing or preventing vascular, cardiovascular arterial or valve calcification in a subject in need comprising administering to the subject an effective amount of an agent that prevents or reduces the expression of HDAC4, an agent that modulates the location of HDAC4, an agent that binds to HDAC4 or an inhibitor of HDAC4 or any combination thereof is provided. In some embodiments, there is provided a pharmaceutical composition comprising: an agent that prevents or reduces the expression of HDAC4, an agent that modulates the location of HDAC4, an agent that binds to HDAC4 or an inhibitor of HDAC4 or any combination thereof; an agent that prevents or reduces the expression of SIK or is an inhibitor of SIK; and/or an agent that prevents or reduces the expression of ENIGMA (Pdlim7) or is an inhibitor of ENIGMA.
-
-
-
-
-
-
-
-
-
Search Results
173
records
(took 0.026 seconds)
